Thursday 10th July 2008
|Text too small?|
The owner of specialist medical clinics is to post full-year earnings later this month. In March it forecast an annual profit of NZ$7.9 million and chief executive Alan Clarke said he stands by the prediction.
"We're happy with the numbers," Clarke told BusinessWire in an interview. "Abano's core financial performance remains strong with pleasing improvements in all businesses over the previous year."
Abano has outperformed the NZX 50 Index in the past 12 months, gaining more than a fifth while the index sunk about 25%. Two suitors, the Stewart family's Masthead Portfolios and Crescent Capital Partners, have sought to control Abano in the past year, driving the stock price to more than NZ$5.10.
Directors of Abano didn't recommend Crescent's NZ$5.20-a-share offer, which was at the low end of a NZ$5.20-to-NZ$5.80 range from independent valuers KordaMentha. Crescent now owns 19.9% of Abano after failing to reach its takeover target.
The company acquired 70% of an Australian dental practice with plans to expand in Queensland state, it said in June. The new addition would contribute A$15 million to annual revenue and stoke profit this year, Abano said last month.
Abano stock was recently unchanged at NZ$4.49 and has jumped about 32% in the past 10 months.
No comments yet
Abano mulls rebel shareholder request for meeting, affirms support for Janes
Hutson fails to respond to Abano buyout offer, takeover 'rife with insider elements'
Abano steps up pressure on bidders over audiology unit price
Abano shareholders clamour for discounted stock in share purchase plan
Hutson quits Abano board after urging from other directors
Abano board questions Hutson's conflict of interest in takeover bid
Abano continues to resist takeovers, rejects approach from Archer, Hutson
Abano seeks $18.5 mln in share purchase plan
Abano shares climb to 4-month high amid prospect of takeover bid
Abano faces takeover bid after rejecting unsolicited offer